The International Society of Female Professionals Recognizes Dr. Lateefat Kikelomo Amao

Dr. Lateefat Kikelomo Amao is a public health physician with over twelve years of experience in public health and projects. She holds an MD from Olabisi Onabanjo University Nigeria and a master’s degree in public health from the University of Manchester.

She is an M.Sc. student in Healthcare Informatics at Middle Tennessee State University, where she works as a Graduate Research Assistant. She provides professional-level support and assistance to research activities that support the unit’s activities under a faculty member’s supervision. Her primary focus is to leverage technology and data analytics to improve the performance of health systems in resource-constrained settings.

She served as Senior Medical Officer II in the Health Emergency Preparedness and Response at the Nigeria Centre for Disease Control and Prevention (NCDC), Abuja, Nigeria.

Lateefat has worked at the National level at the Nigeria Centre for Disease Control and Prevention (NCDC) as the head of the Risk Assessment unit in the Health Emergency Preparedness and Response department. She worked with her team to characterize an impending disease of public health importance and recommend public health actions to mitigate the effect of such across all 36 states of Nigeria.

She led the National Rapid Response Team to support multiple outbreaks in states in Nigeria for COVID-19, Lassa Fever, Monkey Pox, Yellow Fever, and Cerebro-spinal Meningitis. Her work has improved the public health and quality of life of people on a global scale. Dr Amao excels in providing professional-level support and assistance to research activities and delivering valuable experience gained working in health emergency preparedness and response.

Dr. Amao has contributed to developing national clinical and therapeutic guidelines for COVID-19, Capacity building of physicians on COVID-19, Mpox, Lassa fever, Yellow Fever and Measles case management. She worked alongside other colleagues in mapping COVID-19 treatment centres across Nigeria. She has also supported clinical care for other infectious diseases such as Lassa fever, Cerebrospinal Meningitis, Yellow fever, and Mpox.

She also served as the National Incident Manager (IM) for the country’s Mpox (formerly called Monkeypox) Technical Working Group before and during the global outbreak of the disease. She led the conceptualization, planning, and implementation of the preparedness and response effort against Mpox in Nigeria across the 36 states and the Federal Capital Territory (FCT), coordinated partnership, resource mobilization, and capacity building of health workers at national and sub-national levels.

Lateefat Kikelomo Amao has published several research papers on infectious diseases, including Monkeypox, Lassa Fever, and Canine Coronavirus. She has also contributed to developing national clinical and therapeutic guidelines for COVID-19.
Dr. Amao’s work has improved public health and the quality of life of people on a global scale. She is a member of the International Society of Female Professionals and looks forward to networking with other professionals in the field.

Email: kikelomoolajide@gmail.com
LinkedIn Profile: https://www.linkedin.com/in/lateefat-amao-md-mph-469915154/

PUBLICATIONS
1. Trend and enhanced Monkeypox surveillance during COVID-19 pandemic in Nigeria, 2022 -Journal of Public Health in Africa. May 2022. Available at https://www.publichealthinafrica.org/jphia/article/view/2184

2. Outbreak Investigation of Monkeypox in Akwa Ibom State; A matched Case-Control Study 14th-24th October 2019 – East African Journal of Health and Science. Volume 4, Issue 1, 2019.
Available at https://journals.eanso.org/index.php/eajhs/article/view/57

3. Descriptive epidemiology of the burden of human monkeypox in Nigeria, a retrospective review 2017 – 2021. July 2022
Available at https://www.one-health.panafrican-med-journal.com/content/article/8/12/pdf/12.pdf

4. Monkeypox Risk and Mortality associated with HIV infection; A National case-control study in Nigeria. July 2022
Available at Monkeypox Risk and Mortality Associated with HIV Infection: A National Case Control Study in Nigeria by Adesola Yinka-Ogunleye, Mahmood Dalhat, Afolabi Akinpelu, Olusola Aruna, Fatima Garba, Adama Ahmad, Adesola Adeleye, Iliya Botson, Bamidele Oluwafemi, Udemme Ekrikpo, Oladipo Ogunbode, Lateefat Amao, Aliyu Gambo, Ifedayo Adetifa, Chikwe Ihekweazu, Ibrahim Abubakar :: SSRN

5. Capacity building in Monkeypox public outreach, sample and case management for human and animal healthcare workers using a train-trainer approach. An innovative one health strategy for outbreak response and epidemic preparedness.
6. Vaccination for Monkeypox prevention in persons with high-risk sexual behaviours to control ongoing outbreaks of Monkeypox virus clade 3.
Available at https://www.ijidonline.com/article/S1201-9712(22)00378-2/fulltext

7. Canine Coronavirus in Nigeria; A missed diagnosis or an under-reported panzootic – PanAfrican Medical Journal. Volume 4, Article 14, 2020.
Available at https://www.one-health.panafrican-med-journal.com/content/article/4/14/full/

8. Exposure Incidents and Outcome of Lassa Fever Virus (LASV) Infection among Healthcare Workers in Nigeria, 2019 – Journal of Infectious Disease and Epidemiology 2020. Volume 6 Issue 5.
Available at https://clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-6-168.php?jid=jide

9. A description of Lassa Fever mortality during the 2019 outbreak in Nigeria, December 2020. International Journal of Infectious disease.101:409-410
Available at https://www.ijidonline.com/article/S1201-9712(20)31790-2/fulltext#:~:text=Results%3A%20Between%20January%20and%20May,female%20ratio%20of%202%3A1.
10. Reducing the threat of epidemic-prone infections at Mass gatherings and religious events. June 2022.
Available at https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01194-1/fulltext